Navigation Links
Eczema Non-Profit Seeks To Shine New Light On Overlooked Condition
Date:7/1/2012

Indian Harbour Beach, Florida (PRWEB) July 01, 2012

ITSAN, a non-profit charity, is on a mission to combat the global health crisis that is Topical Steroid Addiction. The organization’s main effort is to reach Eczema patients with information about the correlation between Topical Steroids and worsening Eczema. Topical Steroids are the main medication used to treat Eczema.

“In 30 years of practice I have seen over 2,000 patients who initially had Eczema, either in youth, teen years or early adulthood. Each patient started off using Cortisone Creams. When the initial dose and potency no longer worked they were prescribed a higher potency with more frequent usage. In addition often pills and injections of cortisone were given,” recounts Dr. Rapaport.

“In all cases we decided to stop steroids and lo and behold, in one to three years, they were all cured. However, in each case the patient experienced a painful and debilitating withdrawal. They would swell, ooze, have difficulty functioning in school or work, scratch continually, and couldn’t sleep; we had to support them with other medication and keep them off steroids,” stated Dr. Rapaport.

Kelly Palace, president and Co-Founder of ITSAN, was diagnosed in 2009 with Steroid Induced Eczema caused by her Topical Steroid Addiction. Kelly decided to start a website to chronicle her recovery and alert people of the dangers associated with Topical Steroids. Since starting the site she has had over 100,000 web visits.

“I was critically covered in full body Eczema with no recourse. I was given Corticosteroid after Corticosteroid and told there was nothing else I could do. I was getting worse and worse until I found Dr. Rapaport’s articles; he saved my life,” said ITSAN President Kelly Palace.

Kelly discovered thousands of people like her, over the Internet, suffering the same Eczema like “incurable” symptoms. Whenever they stopped applying Topical Steroids their skin would flare, burn, and turn red. “Once we each discovered the research, which depicted these exact withdrawal symptoms, we knew our cure was in sight,” said Kelly Palace.

ITSAN’s goals include educating Eczema patients about this medical issue. Gaining more recognition amongst the broader medical community about Topical Steroid Addiction. Labeling changes to Topical Steroids to better warn patients, and patient treatment options for a monitored and less painful withdrawal process.

Kelly Palace has high hopes for those who are still suffering. “We hope that if you’re suffering that you get the help and support you need from the ITSAN resources and our global, community support groups.”

To learn more about Dr. Marvin Rapaport and his research on Topical Steroid Addiction, please visit http://itsan.org/research-and-resources.html#Dr._Marvin_Rapaport

About The International Topical Steroid Addiction Network

ITSAN was officially Co-Founded by Dermatologist Dr. Marvin Rapaport, full professor at UCLA Medical Center and the nations leading expert on the subject. Kelly Palace, Co-Founder and president, was one of the 2,000 patients that Dr. Rapaport treated and cured. An online community of over 100 patients with this condition also contributed ideas, money and inspiration to start ITSAN. For more information please visit http://itsan.org

Read the full story at http://www.prweb.com/releases/2012/7/prweb9659853.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Prenatal Exposure to Common Household Chemical Linked to Eczema
2. Prenatal exposure to common household chemical increases risk for childhood eczema, study says
3. Avid Collector Seeks Jimi Hendrix 1968 Electric Factory Philadelphia Concert Poster
4. Electronic data methods research seeks to build a learning health care system
5. Trial seeks to sniff out cancer
6. FDA Seeks to Limit Antibiotics in Animal Feed
7. Lighthouse Worldwide Solutions Now Monitors Air Quality in Hospitals and Operating Rooms
8. Bees shed light on human sweet perception and metabolic disorders
9. DRE Medical Equipment Unveils FX-300+ Surgical Headlight and Light Source
10. Special Needs Spotlight: Former SFMTA Board Member Bruce Oka Receives Treatment with San Francisco Sedation Dentist Dr. David Blende
11. Could Sunlight Lower Your Odds for Pancreatic Cancer?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: